Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 5
2021 10
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
A survey of experts to identify methods to detect problematic studies: Stage 1 of the INSPECT-SR Project.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Avenell A, Barbour V, Bordewijk EM, Brown NJL, Clarke M, Dumville J, Grohmann S, Gurrin LC, Hayden JA, Hunter KE, Lam E, Lasserson T, Li T, Lensen S, Liu J, Lundh A, Meyerowitz-Katz G, Mol BW, O'Connell NE, Parker L, Redman B, Seidler AL, Sheldrick K, Sydenham E, Dahly DL, van Wely M, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: meyerowitz katz g. medRxiv [Preprint]. 2024 Mar 25:2024.03.18.24304479. doi: 10.1101/2024.03.18.24304479. medRxiv. 2024. PMID: 38585914 Free PMC article. Preprint.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour G, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville JC, Grey A, Grohmann S, Gurrin L, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O'Connell NE, Parker L, Redman BK, Seidler L, Sheldrick KA, Sydenham E, Torgerson D, van Wely M, Wang R, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: meyerowitz katz g. BMJ Open. 2024 Mar 11;14(3):e084164. doi: 10.1136/bmjopen-2024-084164. BMJ Open. 2024. PMID: 38471680 Free PMC article.
Is Paxlovid Still Worth It?
Faust JS, Meyerowitz-Katz G. Faust JS, et al. Among authors: meyerowitz katz g. Clin Infect Dis. 2024 Feb 27:ciae106. doi: 10.1093/cid/ciae106. Online ahead of print. Clin Infect Dis. 2024. PMID: 38412357 No abstract available.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour V, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville J, Grey A, Grohmann S, Gurrin LC, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O' Connell NE, Parker L, Redman BK, Seidler AL, Sheldrick KA, Sydenham E, Torgerson DJ, van Wely M, Wang R, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: meyerowitz katz g. medRxiv [Preprint]. 2023 Nov 13:2023.09.21.23295626. doi: 10.1101/2023.09.21.23295626. medRxiv. 2023. PMID: 37873409 Free PMC article. Updated. Preprint.
Diabetic Retinopathy Screening at the Point of Care (DR SPOC): detecting undiagnosed and vision-threatening retinopathy by integrating portable technologies within existing services.
Weerasinghe LS, Dunn HP, Fung AT, Maberly G, Cheung NW, Weerasinghe DP, Liew G, Do H, Hng TM, Pryke A, Marks SI, Nguyen H, Jayaballa R, Gurung S, Ford B, Bishay RH, Girgis CM, Meyerowitz-Katz G, Keay L, White AJ. Weerasinghe LS, et al. Among authors: meyerowitz katz g. BMJ Open Diabetes Res Care. 2023 Aug;11(4):e003376. doi: 10.1136/bmjdrc-2023-003376. BMJ Open Diabetes Res Care. 2023. PMID: 37532459 Free PMC article.
37 results